junotherapeutics.com
CelgeneJuno Therapeutics is a clinical-stage company developing novel cellular immunotherapies based on two distinct and complementary platforms – Chimeric Antigen
http://www.junotherapeutics.com/
Juno Therapeutics is a clinical-stage company developing novel cellular immunotherapies based on two distinct and complementary platforms – Chimeric Antigen
http://www.junotherapeutics.com/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Wednesday
LOAD TIME
0.4 seconds
16x16
32x32
64x64
128x128
TERMINAL B LLC
GREG BIBEAU
4301 W. ●●●●●●●●ANNON DR
SUITE●●●●● #302
AU●●IN , TX, 78749
US
View this contact
TERMINAL B LLC
GREG BIBEAU
4301 W. ●●●●●●●●ANNON DR
SUITE●●●●● #302
AU●●IN , TX, 78749
US
View this contact
TERMINAL B LLC
GREG BIBEAU
4301 W. ●●●●●●●●ANNON DR
SUITE●●●●● #302
AU●●IN , TX, 78749
US
View this contact
BUY YOUR DOMAIN
10
YEARS
7
MONTHS
24
DAYS
ENOM, INC.
WHOIS : whois.enom.com
REFERRED : http://www.enom.com
PAGES IN
THIS WEBSITE
20
SSL
EXTERNAL LINKS
91
SITE IP
104.199.127.98
LOAD TIME
0.359 sec
SCORE
6.2
Celgene | junotherapeutics.com Reviews
https://junotherapeutics.com
Juno Therapeutics is a clinical-stage company developing novel cellular immunotherapies based on two distinct and complementary platforms – Chimeric Antigen
Investor Relations | Juno Therapeutics
Juno Therapeutics is a clinical-stage company developing novel cellular immunotherapies based on two distinct and complementary platforms Chimeric Antigen Receptors (CARs) and T Cell Receptors (TCRs) technologies. Our goal is to revolutionize medicine by re-engaging the body’s immune system to treat cancer. Q2 2015 Juno Therapeutics Earnings Conference Call. August 12, 2015. 160;at 2:00 pm PT. Q2 2015 Juno Therapeutics Earnings Conference Call. Wednesday, August 12, 2015 . 2:00 pm PT . Aug 12, 2015.
junotherapeutics.com
Board Of Directors | Juno Therapeutics Juno Therapeutics
https://www.junotherapeutics.com/about-us/board-of-directors
News & Events. News & Events. The Juno Board of Directors is comprised of industry leaders with an outstanding track record of navigating novel science and building enduring companies. Hal Barron is President, Research and Development at Calico, a Google-back biotechnology company focused on the aging process. Hans E. Bishop is one of our co-founders and has served as our Chief Executive Officer and a member of our board of directors since September 2013. Mary Agnes (Maggie) Wilderotter. Maggie Wilderott...
Scientific Advisors | Juno Therapeutics Juno Therapeutics
https://www.junotherapeutics.com/about-us/scientific-advisors
News & Events. News & Events. Juno’s Scientific Advisors provide diversified expertise across our external advisory network. José Baselga, M.D., Ph.D. Chairman of Clinical Advisory Board. Jeff Bluestone, Ph.D. Jeffrey Bluestone was appointed Executive Vice Chancellor and Provost at the University of California, San Francisco (UCSF), in March 2010, having served in a number of posts including Director, UCSF Diabetes Center and the Immune Tolerance Network and as Interim Vice Chancellor. Dr Bluestone earne...
About Us | Juno Therapeutics Juno Therapeutics
https://www.junotherapeutics.com/about-us
News & Events. News & Events. Juno is led by a management team with diverse backgrounds and talents, with the common goal of revolutionizing medicine through developing a broadly applicable cell-based platform. The Juno Board of Directors is comprised of industry leaders with a track record of navigating novel science and building enduring companies. Juno brings together some of the world’s leaders in oncology, immunology, and cell therapy who are pioneers in the CAR and TCR space. Seattle, WA 98109.
Administrator | Juno Therapeutics Juno Therapeutics
https://www.junotherapeutics.com/author/eric
News & Events. News & Events. All posts by Administrator. Juno named to MIT Technology Review’s 50 Smartest Companies 2015. Why Juno Therapeutics, Inc. Cares About the Indiana Religious Freedom Restoration Act. At Juno we believe strongly that no one should be discriminated against due to their sexual orientation, gender identity, or any other improper basis. As a consequence we have been closely following the news about Indiana’s new Religious Freedom Restoration Act. Apply for this position. We are del...
Current Openings | Juno Therapeutics Juno Therapeutics
https://www.junotherapeutics.com/working-at-juno/current-openings
News & Events. News & Events. Having trouble submitting you resumes to Juno? Please email jobs@junotherapeutics.com. And tell us what's happening. 307 Westlake Avenue N., Suite 300. Seattle, WA 98109. Browse our Current Job Openings. Terms & Conditions.
TOTAL PAGES IN THIS WEBSITE
20
~:: WIB :: Women In Bio ::~
http://www.womeninbio.org/wib-chapters/rtp
Sign Up For Newsletter. Sorry, our website is not compatible with your browser. Please update your browser with the latest version or try a different browser. Research Triangle Park (RTP) is one of the oldest and largest high-tech research and development centers in North America. It is part of North Carolina's overall biotechnology initiative. The WIB-RTP chapter benefits from, and contributes to the rich life sciences industry here: North Carolina ranks biotechnology as one of the top three industries ...
CAR T Cell Cancer Immunotherapy | Novel Targets Podcast
http://noveltargets.com/2015/04/promise-of-car-t-cell-cancer-immunotherapy
This is a placeholder for your sticky navigation bar. It should not be visible. April 2, 2015. Prologue 1: Promise of CAR T Cell Cancer Immunotherapy. One of the hottest topics in Cancer Research is using the body’s immune system to fight cancer. This report discusses the promise of Chimeric Antigen Receptor (CAR) T Cell Therapy. It was previously broadcast on the Sound Medicine Radio Hour. On March 22, 2015. Dr Stephan Grupp presents data at ASH 2014 media briefing moderated by Dr Catherine Bollard.
April, 2014 | VC Trends
http://www.vctrends.com/2014/04
Read the Latest Technology and Startup News. Funding Round: Juno Therapeutics, Connectivity, Slack, Wanderful. A biotech company, which concentrates on delivering immunotherapies to battle cancer, has raised a $176 million in Series A. Investors include ARCH Venture Partners and the Alaska Permanent Fund via a partnership managed by Crestline Investors, says a press release. Founding funders, Bezos Expeditions, Jeff Bezos, and Venrock also participated in this round. Funding Roundup: Tradier, Synack, CRI...
Zuckermann People
http://www.ronznet.com/RZ_People.html
Ronald Zuckermann, Ph.D. Lawrence Berkeley National Laboratory (2006 - present). PhD Chemistry and Pharmaceutical Sciences, University of Trieste, 2012 (Prato/Bianco). Principal Scientific Engineering Associate. MS Chemistry, Texas A&M, 1999. Postdoctoral Fellow (Steve Whitelam/Ron Zuckermann). Previous: Postdoctoral Fellow, Universiteit Utrecht. PhD Chemical Engineering, U. Massachussettes Amherst, 2012 (Peter Monson). BS Molecular Biology, Scripps College, 2005. Graduate Student, Nanogeoscience, Univer...
~:: WIB :: Women In Bio ::~
http://www.womeninbio.org/wib-chapters/austin-area
Sign Up For Newsletter. Sorry, our website is not compatible with your browser. Please update your browser with the latest version or try a different browser. The many internationally recognized hospitals and medical research centers in Texas attract a highly skilled network of trained hospital staffers, nurses and doctors, as well as clinical trial organizations. Our Young Women In Bio. WIB-Austin Area Presents "Get to know WIB-Austin Area! September 23, 2016. WIB-Austin Professional Development: "How c...
~:: WIB :: Women In Bio ::~
http://www.womeninbio.org/news
Sign Up For Newsletter. Sorry, our website is not compatible with your browser. Please update your browser with the latest version or try a different browser. Theresa McNeely Joins WIB Board of Directors. WIB is pleased to announce the addition of Ms. Theresa McNeely. To its Board of Directors. WIB Offers a Back to School Discount! If you've considered joining Women In Bio, September is the time! Our Back To School Promotion starts on September 1, 2016! To become a WIB member. Program, the organization a...
Top 10 Early-Stage Venture Capital Deals of 2014 (VC 100) – How To Be Professional on anything
http://www.howtobe.pro/top-10-early-stage-venture-capital-deals-of-2014-vc-100
Friday , August 26 2016. How To Be Professional on anything. Life is simple. YOLO. The Principles of Mobile Web Design. 2 X PHP Developers – Cheltenham – 40,000. Front End Developer (Remote Work). Senior) Frontend Engineer (m/f) wanted! Berlin – Germany). Front End Developer – Berkshire – Contract – 3 Months. Make quantity Ordering With CSS/CSS3. Use smarter Grids With Sass And Susy. Learn Symfony2 to be a professional. Top 10 Early-Stage Venture Capital Deals of 2014 (VC 100). February 27, 2015. Juno Th...
Testimonials | Uniquely HR - Seattle, WA
http://uniquelyhr.com/clients
Why We Do What We Do. These are just some of the companies we’ve had the pleasure of working with. Here are their testimonials. 8220;We contracted with uniquelyHR to facilitate an Executive Team retreat. The uniquelyHR consultant made sure he understood our culture and our most pressing issues up front. It was an engaging 1-day session that helped move the team forward.”. Peter Godman – CEO, Qumulo. Robin Andrulevich – SVP People, Juno Therapeutics. James Gwertzman – CEO, PlayFab. 8220;Mary’s Place is gr...
TOTAL LINKS TO THIS WEBSITE
91
Professional Shopify Themes | Shopify Template Club | Customwork Services | JunoThemes
Start your free trial. Shopify is a leading cloud-based, multichannel commerce plat-. Form designed for small and medium-sized businesses. Start your free trial. Get access to all the best Shopify Themes. Fresh Food Shopify Theme. Of Impressive Shopify Themes. We deliver beautiful and unique Shopify themes to make sure you find a perfect theme for your business. We make it easy for you to customize theme settings from colors to layouts through our robust Basetheme. Privacy & Policy.
Default Web Site Page
If you are the owner of this website, please contact your hosting provider: webmaster@junotherapeutic.biz. It is possible you have reached this page because:. The IP address has changed. The IP address for this domain may have changed recently. Check your DNS settings to verify that the domain is set up correctly. It may take 8-24 hours for DNS changes to propagate. It may be possible to restore access to this site by following these instructions. For clearing your dns cache.
Default Web Site Page
If you are the owner of this website, please contact your hosting provider: webmaster@junotherapeutic.com. It is possible you have reached this page because:. The IP address has changed. The IP address for this domain may have changed recently. Check your DNS settings to verify that the domain is set up correctly. It may take 8-24 hours for DNS changes to propagate. It may be possible to restore access to this site by following these instructions. For clearing your dns cache.
Default Web Site Page
If you are the owner of this website, please contact your hosting provider: webmaster@junotherapeutic.net. It is possible you have reached this page because:. The IP address has changed. The IP address for this domain may have changed recently. Check your DNS settings to verify that the domain is set up correctly. It may take 8-24 hours for DNS changes to propagate. It may be possible to restore access to this site by following these instructions. For clearing your dns cache.
Default Web Site Page
If you are the owner of this website, please contact your hosting provider: webmaster@junotherapeutics.biz. It is possible you have reached this page because:. The IP address has changed. The IP address for this domain may have changed recently. Check your DNS settings to verify that the domain is set up correctly. It may take 8-24 hours for DNS changes to propagate. It may be possible to restore access to this site by following these instructions. For clearing your dns cache.
Celgene
To all Juno Therapeutics website visitors:. Juno Therapeutics is proud to announce it is now a Celgene company. If you would like to access information about Juno and its products and pipeline, please click here:. If you would like information about Celgene Corporation, please visit:. Community Guidelines and Legal Notices. Juno CAR T cell therapies are investigational and not FDA approved. You are now leaving Juno Therapeutics.
Default Web Site Page
If you are the owner of this website, please contact your hosting provider: webmaster@junotherapeutics.info. It is possible you have reached this page because:. The IP address has changed. The IP address for this domain may have changed recently. Check your DNS settings to verify that the domain is set up correctly. It may take 8-24 hours for DNS changes to propagate. It may be possible to restore access to this site by following these instructions. For clearing your dns cache.
Default Web Site Page
If you are the owner of this website, please contact your hosting provider: webmaster@junotherapeutics.mobi. It is possible you have reached this page because:. The IP address has changed. The IP address for this domain may have changed recently. Check your DNS settings to verify that the domain is set up correctly. It may take 8-24 hours for DNS changes to propagate. It may be possible to restore access to this site by following these instructions. For clearing your dns cache.
Default Web Site Page
If you are the owner of this website, please contact your hosting provider: webmaster@junotherapeutics.net. It is possible you have reached this page because:. The IP address has changed. The IP address for this domain may have changed recently. Check your DNS settings to verify that the domain is set up correctly. It may take 8-24 hours for DNS changes to propagate. It may be possible to restore access to this site by following these instructions. For clearing your dns cache.
Default Web Site Page
If you are the owner of this website, please contact your hosting provider: webmaster@junotherapeutics.org. It is possible you have reached this page because:. The IP address has changed. The IP address for this domain may have changed recently. Check your DNS settings to verify that the domain is set up correctly. It may take 8-24 hours for DNS changes to propagate. It may be possible to restore access to this site by following these instructions. For clearing your dns cache.
Default Web Site Page
If you are the owner of this website, please contact your hosting provider: webmaster@junotherapy.biz. It is possible you have reached this page because:. The IP address has changed. The IP address for this domain may have changed recently. Check your DNS settings to verify that the domain is set up correctly. It may take 8-24 hours for DNS changes to propagate. It may be possible to restore access to this site by following these instructions. For clearing your dns cache.
